Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Transdermal System in Adult ADHD
NCT00506285Phase 3Completed
- Sponsor
- University of Utah
- Start
- Jun 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Utah. Started Jun 2007; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00506285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506285.